Biovance, Biovance 3L, Natalin, Acelagraft, Interfyl and Centaflex licensed to NEXGEL are established commercial products widely used today in wound care, orthopedics and other indications. Three ...
Hosted on MSN
Dyadic outlines 2026 product revenue growth and commercialization milestones while expanding partnerships
President & COO Joseph Hazelton indicated that since stepping into the President's role in June 2025, the company has accelerated its transition "from a development stage platform company into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results